Cashu Finance
  • Terminal
  • Stocks
  • Spotlight
  • Research
Log inSign Up
  1. Stocks
  2. Healthcare
  3. NASDAQ
  4. CARL

Market Cap: $400.43M

CI

Carlsmed, Inc.

CARL
NASDAQUSD
Purchase CARL
OverviewNewsAnalyst ReportsFinancialsPolitician TradesInsider TradesExecutivePatentsEarnings Surprise
Cashu Finance

By Cashu Finance. Providing market news, analysis, and research for investors worldwide.

Company

StocksAboutAdvertisersBrokersContact

Legal

Terms of ServicePrivacy Policy

© 2026 Cashu Technologies Pty Ltd. All rights reserved. Cashu Finance is a trademark of Cashu Technologies Pty Ltd.

The content published on Cashu Finance is for informational purposes only and should not be construed as investment advice, a recommendation, or an offer to buy or sell any securities. All opinions expressed are those of the authors and do not reflect the official position of Cashu Technologies Pty Ltd or its affiliates. Past performance is not indicative of future results. Investing involves risk, including the possible loss of principal. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions.

Cashu Finance and its contributors may hold positions in securities mentioned in published content. Any such holdings will be disclosed at the time of publication. Market data is provided on an "as-is" basis and may be delayed. Cashu Technologies Pty Ltd does not guarantee the accuracy, completeness, or timeliness of any information presented.

Executive

Michael John Cordonnier

Co-Founder, Chairman, Chief Executive Officer & President

Compensation
$926,379
Leonard Greenstein

Chief Financial Officer & Treasurer

Compensation
$601,888
Shariq Hussain

Chief Technology Officer

Compensation
Compensation not disclosed
Jenifer Kamocsay

Chief Legal Officer & Secretary

Compensation
Compensation not disclosed
Jeff Bertolini

Senior Vice President of Operational Excellence

Compensation
Compensation not disclosed
Jodi Allen Coe

Senior Vice President of People & Culture

Compensation
Compensation not disclosed
Julie Lamothe

Senior Vice President of Quality & Regulatory Affairs

Compensation
Compensation not disclosed
Stephanie Zhadkevich

VP & Head of Investor Relations

Compensation
Compensation not disclosed
Niall Patrick Casey

Co-Founder, Chief Intellectual Property Officer & Director

Compensation
$522,489
Sharon V. Schulzki

Chief Clinical & Market Access Officer

Compensation
Compensation not disclosed
William Durall

Chief Commercial Officer

Compensation
$713,531